LIMA1-Alpha Protein Predicts Head and Neck Cancer Patients who Can Be Cured with Surgery Alone
Researchers have developed an LIMA1-alpha assay that can identify head and neck cancer patients who can be cured with surgery alone.
Category: Unknown Origin & Other Cancer Types
Unknown Origin & Other Cancer Types
Latest
Unknown Origin & Other Cancer Types
Latest
ExRNA Plays a Role in Head and Neck Cancers
A study highlights the role of exRNA in head and neck cancers (HNCs), emphasizing their potential as non-invasive biomarkers for diagnosis.
Unknown Origin & Other Cancer Types
Latest
FDA Approves Roche’s HER2 Companion Diagnostic for Biliary Tract Cancer Treatment
The PATHWAY HER2 test is a CDx for HER2-positive biliary tract cancer for targeted treatment with Jazz Pharmaceuticals' ZIIHERA.
Researchers Develop Affordable, Rapid Blood Test for Brain Cancer
A new automated device can diagnose glioblastoma in under an hour using a novel electrokinetic biochip that detects active EGFRs from blood.
Read More
News Study Demonstrates Accuracy of Lucid Diagnostics Test for Early Esophageal Cancer Detection
Lucid Diagnostics announced the peer-reviewed publication of an analytical validation study for its EsoGuard Esophageal DNA test.
Read More
Ways2Well Selects Cancer Check Labs as its Provider of Early Cancer Detection Test
Cancer Check Labs has been chosen as the exclusive provider of early cancer detection tests for Ways2Well, a regenerative medicine clinic.
Read More
Can a Mouthwash-Based Test Predict Head and Neck Cancer Recurrence?
Researchers are developing a mouthwash-based test to detect biomarkers that may help predict the recurrence of head and neck cancer.
Read More
FDA Approves Thermo Fisher’s HLA Sequencing System as CDx for Synovial Sarcoma T-Cell Receptor Therapy
Thermo Fisher’s SeCore CDx HLA A Sequencing System received FDA clearance as a CDx for TECELRA, a T-cell receptor therapy from Adaptimmune.
Read More
Blood Test May Guide Use of Multiple Myeloma Immunotherapy
A blood test measuring lymphocyte levels may predict the effectiveness of CAR-T immunotherapy in relapsed multiple myeloma patients.
Read More
Screening Tool Could up Hepatocellular Carcinoma Survival to 90%
A new machine-learning serum fusion-gene model shows promise in increasing hepatocellular carcinoma diagnostic accuracy and monitoring.
Read More
Researchers Identify Biomarker Linked to Renal Cancer Recurrence
Researcher identified a 15-gene signature biomarker that can stratify renal cancer patients into low or high risk of recurrence.
Read More
Rapid Cerebrospinal Fluid Test Decreases Time for Brain Tumors Diagnosis
A new genotyping test using cerebrospinal fluid can rapidly diagnose brain cancers, reducing the need for invasive biopsies.
Read More
New Biomarker Helps Detect Ovarian Cancer Years Before Conventional Diagnosis
Researchers discovered a novel immune-based biomarker that could pave the way for potential early detection of high-grade ovarian cancer.
Read More
Multi-Analyte Blood Test Outperforms Ultrasound in Early Liver Cancer Detection
A clinical trial shows that a Helio Genomics test outperforms ultrasound in detecting hepatocellular carcinoma in liver cirrhosis patients.
Read More
New Saliva-Based Test to Diagnose Oral Cavity CancerÂ
Salignostics has partnered with ARC Innovation at Sheba Medical Center to develop a saliva-based test for detecting oral cavity cancer.
Read More
Ovarian Cancer Detection Method Improvement Over CA125
Mercy BioAnalytics will present data showing that their Mercy Halo test significantly improves early detection of ovarian cancer.
Read More
New Biomarkers Identified for Improve Renal Cancer Diagnosis
Researchers discovered new biomarkers for renal cell carcinomas, enhancing the diagnosis of various subtypes.
Read More
Leptomeningeal Cancer Cell Diagnostic Assay Gets Clinical Trial Implementation
The tumor cell enumeration assay is a diagnostic test that is promising for establishing the diagnosis of leptomeningeal metastases.
Read More